Esperion Therapeutics, Inc. - 8-K Filing

Esperion stockholders approved a merger agreement with Essence Parent Inc. on July 8, 2026. (Items: 5.07 Submission of Matters to a Vote of Security Holders)

SEC EDGAR ·

Tickers: $ESPR

Read the full article at SEC EDGAR

More Regulatory news